ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2116

Artificial Intelligence Classifier for Osteoporosis Detection from Chest Radiographs: Performance Evaluation and Literature Comparison with Quantitative Ultrasound

Miso jang1 and Minjun Kim2, 1Promedius, inc., Seoul Chuk Hospital, Seoul, Republic of Korea, 2Promedius, inc., Seoul, Republic of Korea

Meeting: ACR Convergence 2024

Keywords: Access to care, Clinical Osteoporosis, Health Care, X-ray

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Monday, November 18, 2024

Title: Osteoporosis & Metabolic Bone Disease – Basic & Clinical Science Poster

Session Type: Poster Session C

Session Time: 10:30AM-12:30PM

Background/Purpose: Osteoporosis is a common condition that often goes unnoticed until it results in fractures, significantly increasing morbidity and mortality rates. Recent advancements in deep learning have demonstrated the ability to detect low bone density using simple radiographs, including chest X-rays (CXR). This underscores the urgent need to explore the application of deep learning models for osteoporosis screening in real-world settings.


The initial model, OsPor-Screen(Jang et al. 2022), was validated exclusively using CXRs from the Health screening dataset, which mainly included images from relatively healthy individuals. This limitation restricted its applicability in actual clinical settings. To overcome this, we developed and implemented a robust model specifically for osteoporosis screening in diverse, real-world environments. The new model was validated across various healthcare facilities, representing different stages of the healthcare delivery system and distinct medical settings. Furthermore, we aimed to compare the performance of our model with that of osteoporosis screening using quantitative ultrasound (QUS).

Methods: The CXR:OSTEO was tested with five test datasets. Asan Medical Center (AMC), which is a tertiary hospital, internal test dataset was a part of the training dataset and AMC external dataset was an external dataset from the same hospital. Seoul Chuk Hospital (SCH) specializes in spine and joint care. Veteran Health System Medical Center (VHSMC) provides comprehensive medical and specialized care to veterans and their families. Gradient Health (GH), a leading provider of global medical imaging datasets, offers access to an extensive and diverse collection of 5 million de-identified medical images.

All 5 test datasets comprised paired posteroanterior chest radiographs and Dual-Energy X-ray Absorptiometry (DXA) examinations conducted on individuals aged 50 years and older.The Advanced model, CXR:OSTEO goes further than the OsPor-Screen, which predicts osteoporosis in a single CXR image, to predict osteoporosis in multiple regions of a CXR image. To comprehensively evaluate the screening performance for the two validation datasets, the accuracy, sensitivity, specificity, and area under the ROC curve (AUC) were calculated.

Results: Across more than seven different CXR machines and two different DXA manufacturers in various populations, CXR:OSTEO showed excellent performances in the internal and four external datasets. The AUCs were near and over 0.9 and the result was 0.81 in the global region. For osteoporosis screening guidelines in USPSTF, performance of QUS is 0.77 in women and 0.80 in men.(“Osteoporosis to Prevent Fractures: Screening” 2018) Another study(Adami et al. 2024) also reported that the maximum performance of QUS in a dataset of 200 patients was an AUC of 0.81.

Conclusion: We developed the CXR-OSTEO model to screen for osteoporosis using chest X-rays and validated it with four external test datasets. These results support that screening for osteoporosis using CXR:OTSEO is the most effective method in the real clinical setting.

Supporting image 1

Figure 1. Scheme of OSTEO:CXR

Supporting image 2

Table 1. Demographic characteristics of the datasets

Supporting image 3

The performance metrics of CXR:OSTEO in the internal and external validation datasets


Disclosures: M. jang: Promedius,inc., 3; M. Kim: Promedius,inc., 3.

To cite this abstract in AMA style:

jang M, Kim M. Artificial Intelligence Classifier for Osteoporosis Detection from Chest Radiographs: Performance Evaluation and Literature Comparison with Quantitative Ultrasound [abstract]. Arthritis Rheumatol. 2024; 76 (suppl 9). https://acrabstracts.org/abstract/artificial-intelligence-classifier-for-osteoporosis-detection-from-chest-radiographs-performance-evaluation-and-literature-comparison-with-quantitative-ultrasound/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2024

ACR Meeting Abstracts - https://acrabstracts.org/abstract/artificial-intelligence-classifier-for-osteoporosis-detection-from-chest-radiographs-performance-evaluation-and-literature-comparison-with-quantitative-ultrasound/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology